Evestra, Inc.
10Patents
10Active
10Granted
47Portfolio score
Filing activity: Nov 25, 2009 → Sep 14, 2018 · 3 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8222237B2 | Progestational 3-(6,6-ethylene-17B-hydroxy-3-oxo-17A-pregna-4-ene-17A-yl)propionic acid G-lactones | Chemistry; Metallurgy | 53 | Active |
| US9745338B2 | Pro-drug forming compounds | Chemistry; Metallurgy | 2 | Active |
| US10053485B2 | Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents | Chemistry; Metallurgy | 2 | Active |
| US10273263B2 | Pro-drug forming compounds | Chemistry; Metallurgy | 1 | Active |
| US8673968B2 | Progesterone antagonists | Chemistry; Metallurgy | 1 | Active |
| US10624903B2 | Longer-acting progestin prodrug contraceptives | Chemistry; Metallurgy | 0 | Active |
| US8334375B2 | Methods for the preparation of drospirenone | Chemistry; Metallurgy | 0 | Active |
| US9096641B2 | Imidazolyl progesterone antagonists | Chemistry; Metallurgy | 0 | Active |
| US9850273B2 | Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancer | Chemistry; Metallurgy | 0 | Active |
| US10738075B2 | Cytotoxic agents that preferentially target leukemia inhibitory factor (LIF) for the treatment of malignancies and as new contraceptive agents | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.